Medirom Healthcare Reports October 2024 KPIs
Ticker: MRM · Form: 6-K · Filed: Nov 21, 2024 · CIK: 1819704
Sentiment: neutral
Topics: kpi-update, operational-metrics, press-release
TL;DR
Medirom dropped October KPIs on Nov 21st - check the numbers.
AI Summary
Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for October 2024 in a press release dated November 21, 2024. The company is providing an update on its operational metrics for the month.
Why It Matters
This filing provides investors with timely operational data, allowing them to track the company's performance and growth trajectory in the healthcare technology sector.
Risk Assessment
Risk Level: low — This is a routine update of operational metrics and does not appear to contain significant new financial or strategic information that would inherently increase risk.
Key Players & Entities
- Medirom Healthcare Technologies Inc. (company) — Registrant
- November 21, 2024 (date) — Date of press release
- October 2024 (date) — Period for KPIs
FAQ
What specific Key Performance Indicators (KPIs) are being updated for October 2024?
The filing states that Medirom Healthcare Technologies Inc. is announcing its major Key Performance Indicators, or KPIs, updated for the month of October 2024, but the specific metrics are detailed in Exhibit 99.1, which is not provided in this excerpt.
When was the press release announcing these KPIs issued?
The press release announcing the KPIs was issued on November 21, 2024.
What is the purpose of this Form 6-K filing?
This Form 6-K report is being filed to furnish a press release announcing the company's major Key Performance Indicators for October 2024.
Does this filing include Medirom's annual report?
No, this filing is a Form 6-K, which is a report of a foreign private issuer. The company indicates it files annual reports under cover of Form 20-F.
Where is Medirom Healthcare Technologies Inc. headquartered?
Medirom Healthcare Technologies Inc. is headquartered at 2-3-1 Daiba, Minato-ku, Tokyo, Japan.
Filing Stats: 275 words · 1 min read · ~1 pages · Grade level 13.5 · Accepted 2024-11-21 06:01:27
Filing Documents
- tmb-20241121x6k.htm (6-K) — 16KB
- tmb-20241121xex99d1.htm (EX-99.1) — 101KB
- tmb-20241121xex99d1001.jpg (GRAPHIC) — 5KB
- tmb-20241121xex99d1003.jpg (GRAPHIC) — 47KB
- tmb-20241121xex99d1004.jpg (GRAPHIC) — 43KB
- tmb-20241121xex99d1005.jpg (GRAPHIC) — 44KB
- tmb-20241121xex99d1006.jpg (GRAPHIC) — 35KB
- tmb-20241121xex99d1007.jpg (GRAPHIC) — 41KB
- tmb-20241121xex99d1008.jpg (GRAPHIC) — 41KB
- tmb-20241121xex99d1009.jpg (GRAPHIC) — 42KB
- 0001558370-24-015878.txt ( ) — 529KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MEDIROM HEALTHCARE TECHNOLOGIES INC. Date: November 21, 2024 By: /s/ Fumitoshi Fujiwara Name: Fumitoshi Fujiwara Title: Chief Financial Officer